Skip to main content

Dapagliflozin (Amorphous)

Therapy Area
Anti-Diabetic
API Technology
Synthetic
Formulation
Oral Solids
Development Status
Available
Available Regulatory Filing
USA
Korea
Europe
Innovator Brand (US)
FARXIGA

We are here to help, if you have any country specific requirements - please Contact Us.